| Asthma |
1.91 |
5.86e-2 |
25/31 (80.65%) |
HLA-DQB1;PRG2;FCER1A;...
|
| Alcoholism |
1.74 |
1.90e-1 |
86/186 (46.24%) |
GNG11;PKIA;GNAI1;...
|
| DNA replication |
1.64 |
3.35e-1 |
34/36 (94.44%) |
PCNA;FEN1;POLE2;...
|
| Proteasome |
1.60 |
4.13e-1 |
44/46 (95.65%) |
PSMA6;PSMB5;PSMC3;...
|
| Oxidative phosphorylation |
1.55 |
5.00e-1 |
93/133 (69.92%) |
NDUFB3;NDUFAB1;NDUFB6;...
|
| Steroid biosynthesis |
1.53 |
4.67e-1 |
19/20 (95%) |
SC5D;DHCR24;HSD17B7;...
|
| Systemic lupus erythematosus |
1.52 |
4.62e-1 |
45/135 (33.33%) |
HLA-DQB1;C7;CTSG;...
|
| Renin secretion |
1.51 |
4.30e-1 |
61/69 (88.41%) |
GNAI1;GUCY1A1;KCNJ2;...
|
| Melanogenesis |
1.50 |
4.33e-1 |
74/101 (73.27%) |
GNAI1;CREB1;FZD2;...
|
| Parkinson disease |
1.49 |
3.95e-1 |
176/249 (70.68%) |
GNAI1;GPR37;SLC6A3;...
|
| Vasopressin-regulated water reabsorption |
1.49 |
3.75e-1 |
40/44 (90.91%) |
AQP3;CREB1;GNAS;...
|
| Hematopoietic cell lineage |
1.48 |
3.63e-1 |
90/99 (90.91%) |
CD36;HLA-DQB1;CD55;...
|
| Regulation of lipolysis in adipocytes |
1.47 |
3.69e-1 |
52/55 (94.55%) |
GNAI1;PTGS2;NPY;...
|
| Phagosome |
1.47 |
3.47e-1 |
118/152 (77.63%) |
CD36;HLA-DQB1;TLR4;...
|
| Valine, leucine and isoleucine degradation |
1.46 |
3.27e-1 |
42/48 (87.5%) |
HMGCS2;HMGCS1;AOX1;...
|
| Viral myocarditis |
1.45 |
3.33e-1 |
53/60 (88.33%) |
HLA-DQB1;CD55;HLA-DMB;...
|
| Synaptic vesicle cycle |
1.45 |
3.13e-1 |
63/78 (80.77%) |
SLC1A1;SLC6A3;ATP6V1A;...
|
| Base excision repair |
1.45 |
3.01e-1 |
29/33 (87.88%) |
PCNA;FEN1;POLE2;...
|
| Renin-angiotensin system |
1.44 |
3.03e-1 |
20/23 (86.96%) |
CTSG;ENPEP;CPA3;...
|
| Serotonergic synapse |
1.43 |
3.27e-1 |
97/114 (85.09%) |
GNG11;GNAI1;PTGS2;...
|
| Ras signaling pathway |
1.41 |
3.54e-1 |
201/232 (86.64%) |
GNG11;EGF;RAPGEF5;...
|
| Nucleotide excision repair |
1.39 |
4.09e-1 |
40/47 (85.11%) |
PCNA;RAD23B;POLE2;...
|
| Diabetic cardiomyopathy |
1.38 |
4.10e-1 |
162/203 (79.8%) |
CD36;PLN;ATP2A1;...
|
| Intestinal immune network for IgA production |
1.38 |
3.98e-1 |
38/48 (79.17%) |
HLA-DQB1;CXCL12;HLA-DMB;...
|
| Circadian entrainment |
1.34 |
4.88e-1 |
85/97 (87.63%) |
GNG11;RPS6KA5;GNAI1;...
|
| Arachidonic acid metabolism |
1.34 |
4.71e-1 |
48/61 (78.69%) |
PTGS2;ALOX5;PLAAT3;...
|
| Synthesis and degradation of ketone bodies |
1.33 |
4.82e-1 |
9/10 (90%) |
HMGCS2;HMGCS1;BDH2;...
|
| Calcium signaling pathway |
1.33 |
4.65e-1 |
213/240 (88.75%) |
EGF;PDGFD;NTRK2;...
|
| Drug metabolism |
1.31 |
5.20e-1 |
78/151 (51.66%) |
FMO1;UGT2B28;GSTA1;...
|
| Alzheimer disease |
1.30 |
5.18e-1 |
279/369 (75.61%) |
DKK1;PTGS2;ATP2A1;...
|
| Porphyrin and chlorophyll metabolism |
-1.27 |
4.34e-1 |
23/43 (53.49%) |
FECH;ALAS2;HEPH
|
| Coronavirus disease |
-1.29 |
4.26e-1 |
215/232 (92.67%) |
VWF;C9;EGFR;...
|
| Measles |
-1.29 |
4.35e-1 |
133/139 (95.68%) |
FADD;RELA;BBC3;...
|
| Mannose type O-glycan biosynthesis |
-1.31 |
3.97e-1 |
14/23 (60.87%) |
B3GAT1;B4GALT3;LARGE1;...
|
| Fructose and mannose metabolism |
-1.33 |
3.71e-1 |
30/33 (90.91%) |
PFKFB3;SORD;HKDC1;...
|
| Galactose metabolism |
-1.33 |
3.85e-1 |
26/31 (83.87%) |
B4GALT2;GALT;HKDC1;...
|
| GnRH secretion |
-1.36 |
3.36e-1 |
60/64 (93.75%) |
CACNA1C;ARRB2;ARRB1;...
|
| Inositol phosphate metabolism |
-1.36 |
3.41e-1 |
66/73 (90.41%) |
ITPKA;PIK3CG;TPI1;...
|
| Focal adhesion |
-1.38 |
3.24e-1 |
180/201 (89.55%) |
COL6A1;COL4A5;PTEN;...
|
| Amino sugar and nucleotide sugar metabolism |
-1.39 |
3.11e-1 |
38/48 (79.17%) |
GALT;HKDC1;CHIA;...
|
| TNF signaling pathway |
-1.39 |
3.19e-1 |
103/112 (91.96%) |
JUNB;MAPK13;IL6;...
|
| Sulfur metabolism |
-1.39 |
3.28e-1 |
9/10 (90%) |
MPST;SELENBP1;TST
|
| Rheumatoid arthritis |
-1.40 |
3.37e-1 |
78/93 (83.87%) |
CTSK;IL1A;ATP6AP1;...
|
| RIG-I-like receptor signaling pathway |
-1.41 |
3.13e-1 |
64/70 (91.43%) |
MAPK14;IFNA1;IRF3;...
|
| Glycolysis / Gluconeogenesis |
-1.42 |
3.10e-1 |
56/67 (83.58%) |
TPI1;G6PC3;PDHA2;...
|
| Thyroid hormone synthesis |
-1.43 |
3.01e-1 |
66/75 (88%) |
GPX1;TPO;GPX7;...
|
| Neomycin, kanamycin and gentamicin biosynthesis |
-1.45 |
2.80e-1 |
5/5 (100%) |
HKDC1;HK2;HK1
|
| NOD-like receptor signaling pathway |
-1.47 |
2.61e-1 |
145/181 (80.11%) |
HSP90AA1;MAPK13;IL6;...
|
| Vitamin digestion and absorption |
-1.47 |
2.78e-1 |
17/24 (70.83%) |
SLC19A2;SCARB1;APOA1;...
|
| Legionellosis |
-1.48 |
2.93e-1 |
51/57 (89.47%) |
C3;CXCL1;BNIP3;...
|
| Central carbon metabolism in cancer |
-1.53 |
2.05e-1 |
67/70 (95.71%) |
PDHA2;LDHAL6B;AKT1;...
|
| Amoebiasis |
-1.54 |
2.12e-1 |
99/102 (97.06%) |
COL4A6;LAMC1;SERPINB4;...
|
| Other types of O-glycan biosynthesis |
-1.58 |
1.65e-1 |
29/47 (61.7%) |
GALNT8;B4GALT2;COLGALT1;...
|
| ECM-receptor interaction |
-1.59 |
1.74e-1 |
80/88 (90.91%) |
COL6A1;COL4A5;COL9A3;...
|
| Small cell lung cancer |
-1.59 |
2.03e-1 |
90/92 (97.83%) |
RELA;CDKN1B;COL4A5;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
-1.62 |
2.02e-1 |
62/70 (88.57%) |
MAPK13;JUN;HBEGF;...
|
| Cholesterol metabolism |
-1.65 |
1.60e-1 |
44/50 (88%) |
APOC1;ANGPTL8;VDAC1;...
|
| IL-17 signaling pathway |
-1.77 |
5.85e-2 |
84/94 (89.36%) |
TRAF5;TRAF4;LCN2;...
|
| Mineral absorption |
-1.81 |
6.71e-2 |
48/60 (80%) |
MT2A;MT1G;MT1H;...
|
| Bladder cancer |
-1.89 |
6.20e-2 |
40/41 (97.56%) |
FGFR3;E2F3;ERBB2;...
|
